Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,201.00
Bid: 1,200.60
Ask: 1,201.00
Change: -7.80 (-0.65%)
Spread: 0.40 (0.03%)
Open: 1,216.80
High: 1,222.20
Low: 1,201.00
Yest. Close: 1,208.80
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

RPT-A bitter pill as China crackdowns squeeze pharma margins

(Repeats article first published on Sunday. No changes to text.) By Adam Jourdan SHANGHAI, May 25 (Reuters) - A crackdown on corruption and pricing in China's fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of

25 May 14 21:00

A bitter pill as China crackdowns squeeze pharma margins

By Adam Jourdan SHANGHAI, May 25 (Reuters) - A crackdown on corruption and pricing in China's fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over. A Reuters' analysis of mo

25 May 14 02:00

UPDATE 3-Japanese group Mizkan buys Unilever's pasta sauces for $2.15 bln

* Mizkan Group looks to counter slowing domestic growth * All-cash deal values sauce business at 3.6 times sales * Unilever restructuring close to completion (Adds deal advisers) By Martinne Geller and Paul Sandle LONDON, May 22 (Reuters) - Mizkan Group has agreed to buy

22 May 14 14:37

UPDATE 2-Japanese group buys Unilever's pasta sauces for $2.15 bln

* Mizkan Group looks to counter slowing domestic growth * All-cash deal values sauce business at 3.6 times sales * Unilever restructuring close to completion (Writes through, adds context, analyst comment) By Martinne Geller and Paul Sandle LONDON, May 22 (Reuters) - Miz

22 May 14 13:54

UPDATE 2-China anti-graft watchdog visits Roche amid pharma crackdown

* Swiss drugmaker says specific details unclear * China cracking down on wider pharma sector (Adds comment from SAIC, updates shares) By Adam Jourdan and Caroline Copley SHANGHAI/ZURICH, May 22 (Reuters) - Swiss drugmaker Roche Holding AG said it had been visited by a unit of

22 May 14 10:36

UPDATE 1-China anti-graft watchdog visits Roche amid pharma crackdown

* China anti-trust watchdog visits Roche office * Swiss drugmaker says specific details unclear * China cracking down on wider pharma sector (Recasts, adds lawyer comment and context) By Adam Jourdan and Caroline Copley SHANGHAI/ZURICH, May 22 (Reuters) - Swiss drugmaker

22 May 14 09:31

Drugmaker Roche says visited by authorities in China

SHANGHAI/ZURICH, May 22 (Reuters) - Swiss drugmaker Roche Holding AG said on Thursday it had been visited by a unit of China's anti-trust regulator, amid increasing scrutiny over business practices in the pharmaceutical sector in the country. "We understand that a local government unit in H

22 May 14 07:04

UPDATE 1-Vaccines group seeks $7.5 bln to protect 300 million children

* Money would fund GAVI's programmes from 2016 to 2020 * GAVI works with drugmakers to cut vaccine costs for poor * 1.5 mln children a year die of vaccine-preventable disease (Updates with pledge from European Union, price freeze from GSK) By Kate Kelland LONDON, May 20

20 May 14 14:28

Drug flops from 2004 haunt AstraZeneca investors

* Standalone strategy hinges on new drugs delivering * AstraZeneca has had more than fair share of flops in past * Experiences with Exanta, other failures haunt company By Ben Hirschler LONDON, May 20 (Reuters) - AstraZeneca's confidence in its promising new drugs may have

20 May 14 13:37

Vaccines group seeks $7.5 bln to protect 300 million children

* Money would fund GAVI's programmes from 2016 to 2020 * GAVI works with drugmakers to cut vaccine costs for poor * 1.5 mln children a year die of vaccine-preventable disease By Kate Kelland LONDON, May 20 (Reuters) - The GAVI global vaccines alliance issued a plea on Tues

20 May 14 08:30

Glaxo, Genmab say disappointed with study of lymphoma treatment

May 19 (Reuters) - GlaxoSmithKline and Danish biotech company Genmab said disappointing results from a study on treating relapsed lymphoma with their ofatumumab drug meant it was unlikely they would seek its regulatory approval. A head-to-head phase III study of ofatumumab and another drug

19 May 14 22:23

Sector movers: AstraZeneca drags pharma stocks lower on Pfizer drama

The pharmaceutical sector was dragged into the red on Monday as shares in AstraZeneca were hit by the news that the board has rejected another offer from US rival Pfizer. AstraZeneca was trading 11.5% lower at 4,270p after turning down a sweetened 5,500p-a-share bid from Pfizer. The new offer, wh

19 May 14 13:52

GSK dodged millions in China drug tax scam - state media

SHANGHAI, May 19 (Reuters) - A Chinese state-run newspaper has accused British drugmaker GlaxoSmithKline Plc of evading at least 100 million yuan ($16.04 million) in taxes, adding to pressure on the firm which is already struggling with graft charges against executives. Chinese police on We

19 May 14 09:58

RPT-Big Pharma beware: GSK China case may be just the beginning

(Repeats from Sunday, no changes to text) By Adam Jourdan and John Ruwitch SHANGHAI, May 18 (Reuters) - Chinese corruption charges against executives of British drugmaker GlaxoSmithKline Plc (GSK) could be just the start of the pharmaceutical industry's problems in its biggest emergin

18 May 14 21:00

Big Pharma beware: GSK China case may be just the beginning

By Adam Jourdan and John Ruwitch SHANGHAI, May 18 (Reuters) - Chinese corruption charges against executives of British drugmaker GlaxoSmithKline Plc (GSK) could be just the start of the pharmaceutical industry's problems in its biggest emerging drugs market, according to industry sources in

18 May 14 11:45

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.